Monthly Archives: July 2012

By ROWENA JOY A. SANCHEZ LT is noticeably more blooming these days (Publicity photo) MANILA, Philippines As if by stroke of magic, Lorna Tolentinos back pain was eliminated after getting stem cell treatment at a hospital in Germany on July 3. The whole process only took four days, which included a day for an interview about her health history. The second day was for the treatment itself, with Lorna receiving 10 injections. She rested on the third day and was discharged on the fourth. In a recent interview with Bulletin Entertainment and some members of the media, Lorna enthused, Ang instant [na nawala] sa akin yung back pain talaga Kasi iba yung pakiramdam ng wala kang iniinda na sakit sa likod. Dati pag lumalakad ako, mabagal Pag lumalakad ako pinupukpok ko na tong paa ko dahil nagna-numb na yung dito (part of her legs) ko. The back pain, she noted, was caused by scoliosis, a disorder that causes an abnormal curve of the spine, or backbone, according to medicinenet.com. Although her aura is noticeably more bloomingwhich can perhaps be attributed to the treatmentthe Kapatid actress emphasized that it will take three months before the changes completely take effect. Such immediate … Continue reading →

ROCKVILLE, Md., July 25, 2012 /PRNewswire/ --Neuralstem, Inc. (NYSE MKT: CUR) announced that the seventeenth patient was treated in the ongoing Phase I trial of its spinal cord neural stem cells for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). This patient is also the second to return to the trial for additional injections. In this treatment, the patient received five injections in the cervical (upper back) region of the spinal cord, in addition to the ten he had previously received in the lumbar (lower back) region, for a total of 15 injections. The final previously treated patient of this cervical cohort is expected to return to the trial in August, provided the inclusion requirements continue to be met. This ground-breaking stem cell trial is taking place at Emory University Hospital in Atlanta, Georgia. (Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO ) "We are pleased that this phase of the trial, in which we have been permitted by the FDA to take the unprecedented step of dosing patients for the second time, is progressing as planned," said Karl Johe, PhD, Neuralstem's Chairman and Chief Scientific Officer. "These are the first patients in the world to receive our cells in both the lumbar … Continue reading →

Mumbai, July 25: How big is small? Nano technologies are igniting innovations across the world. And tracing this nanoscape the complex pathways from nanoventing to the commercialisation of nanovations is the book Nanotechnology Intellectual Property Rights: Research, Design, and Commercialization. The inclusive nature of nanotechnology gives it a very special status as it mothers innovations to deliver inventions in nanobiotechnology, nanostructures, nanocomposites, nanomedicine, nanotaggants for security systems, nanoelectronics, nanodevices etc, according to excerpts from the book written by intellectual property experts Dr Prabuddha Ganguli and Dr Siddharth Jabade. The book is slated for launch in Hyderabad this week. Nanotechnology allows scientists to dabble at the small, building-block atomic or molecular level. And while the technology is not without its sceptics, a section of the scientific community believes that nanotechnology would help develop break-through newer applications in several fields. Illustrating this nano-inclusiveness, the authors say, the protection of intellectual property is important to the nanotechnology industry because of its complex knowledge matrix. Driving the nano to success will require cross-disciplinary expertise to contemplate, foresee and address as many social, legal including intellectual property rights, cultural, ethical, religious, philosophical and political implications of the nanoworld, tomorrow and the days after, the book … Continue reading →

Denver, CO(KSDK) - Thelast time Rick Hamilton was in Denver he'd suffered a stroke at 40,000 feet. Now he returns to the mile high city, reuniting with the team of doctors, nurses and paramedics who saved his life. When Rick Hamilton left Denver's University of Colorado Hospital, he was thankful to be alive. Now nine months later, in lieu of dozens of handwritten notes he'd thought about sending, Hamilton has stopped in to say thanks to the people who saved him. "I've been saying to myself all day, it's going to be tough to get through," said Hamilton. "But I think stroke causes that doesn't it." Hamilton a banking software salesman from Godfrey, Illinois was on a flight headed to Salt Lake City last October when he suffered a stroke at 40,000 feet. The planets seemed to align when a flight attendant noticed Hamilton's symptoms, an emergency room doctor on board diagnosed stroke, and the pilot landed the plane quickly. Hamilton ended up at UCH and in the hands of doctors, nurses and staff trained to deal with stroke and deal with it fast. "Rick as you probably all know was treated in 18 minutes," said Dan Meyers, UCH Communications … Continue reading →

- Next-generation device for ischemic stroke treatment integrates gold standard stent-based clot retriever with integrated protective cover - CAMPBELL, California, July 24, 2012 /PRNewswire/ -- Lazarus Effect, a medical device company focused on improving treatment of acute ischemic stroke through effective removal of the blood clots that cause a stroke, announced today that the Lazarus ReCover Thrombectomy Device hasreceived CE Mark. The Lazarus ReCover is a next-generation ischemic stroke device that addresses a major limitation of stent-based clot retrieval, the current gold-standard technology for clot removal, by integrating a protective cover intended to prevent clot fragmentation or embolism and the potential for secondary stroke. Lazarus Effect plans to launch the Lazarus ReCover in Europe during Q1 2013. The company is currently evaluating distribution partners. Stent-based thrombectomy (clot removal) devices have demonstrated success "capturing" clots within the affected vessel, but often lose thrombus as the device is extracted. Among 124 Solitaire stent retriever cases evaluated during a recent European study, lost clot pieces traveled into an area of the brain previously not affected nine percent of the time, causing new areas of brain to experience stroke. The ReCover device comprises a nitinol wire-wrapped stent with a highly visible, radio-opaque core and … Continue reading →